BSE Live
Oct 29, 11:34Prev. Close
1120.05
Open Price
1097.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1097.65 (61545)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Profit & Loss account of Titan Biotech (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 69.48 | 58.24 | 55.53 | 56.03 | 48.74 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 3.62 | 3.13 | |
| Revenue From Operations [Net] | 69.48 | 58.24 | 55.53 | 52.41 | 45.61 | |
| Total Operating Revenues | 69.48 | 58.24 | 55.53 | 52.41 | 45.61 | |
| Other Income | 0.41 | 0.65 | 0.44 | 0.25 | 0.43 | |
| Total Revenue | 69.89 | 58.89 | 55.98 | 52.65 | 46.04 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 36.74 | 34.50 | 29.71 | 34.20 | 29.72 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 7.66 | 7.04 | 6.53 | 7.33 | 4.55 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -0.65 | -3.88 | 1.31 | -1.60 | -0.40 | |
| Employee Benefit Expenses | 10.03 | 8.49 | 6.92 | 2.77 | 3.37 | |
| Finance Costs | 1.90 | 2.04 | 2.35 | 1.47 | 0.99 | |
| Depreciation And Amortisation Expenses | 1.75 | 1.68 | 0.91 | 0.80 | 0.76 | |
| Other Expenses | 4.84 | 4.68 | 4.47 | 4.21 | 4.47 | |
| Total Expenses | 62.26 | 54.54 | 52.20 | 49.16 | 43.45 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 7.63 | 4.36 | 3.77 | 3.49 | 2.59 | |
| Exceptional Items | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 8.24 | 4.36 | 3.77 | 3.49 | 2.59 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 1.85 | 1.03 | 1.02 | 1.01 | 0.77 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.19 | 0.25 | 0.35 | 0.15 | 0.09 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 2.04 | 1.28 | 1.37 | 1.16 | 0.86 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 6.20 | 3.08 | 2.40 | 2.34 | 1.72 | |
| Profit/Loss From Continuing Operations | 6.20 | 3.08 | 2.40 | 2.34 | 1.72 | |
| Profit/Loss For The Period | 6.20 | 3.08 | 2.40 | 2.34 | 1.72 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 7.50 | 3.73 | 3.10 | 3.02 | 2.23 | |
| Diluted EPS (Rs.) | 7.50 | 3.73 | 3.10 | 3.02 | 2.23 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 13.40 | 8.89 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 20.80 | 20.83 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.70 | 0.70 | 0.58 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | |
| Equity Dividend Rate (%) | 10.00 | 0.00 | 8.00 | 8.00 | 8.00 |
03.06.2025
Titan Biotech Consolidated March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
02.06.2025
Titan Biotech Standalone March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
28.02.2025
Titan Biotech Consolidated December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
17.02.2025
Titan Biotech Standalone December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
03.06.2025
Titan Biotech Consolidated March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
02.06.2025
Titan Biotech Standalone March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
28.02.2025
Titan Biotech Consolidated December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
17.02.2025
Titan Biotech Standalone December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017